Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Tax Provisions (2020 - 2022)

Rani Therapeutics Holdings (RANI) has 3 years of Tax Provisions data on record, last reported at -$254000.0 in Q4 2022.

  • For Q4 2022, Tax Provisions fell 535.0% year-over-year to -$254000.0; the TTM value through Dec 2023 reached -$147000.0, down 310.0%, while the annual FY2022 figure was $70000.0, 70.73% up from the prior year.
  • Tax Provisions reached -$254000.0 in Q4 2022 per RANI's latest filing, down from $107000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $154000.0 in Q2 2022 and bottomed at -$254000.0 in Q4 2022.
  • Average Tax Provisions over 3 years is $12200.0, with a median of $21500.0 recorded in 2020.
  • The widest YoY moves for Tax Provisions: up 15300.0% in 2022, down 535.0% in 2022.
  • A 3-year view of Tax Provisions shows it stood at $5000.0 in 2020, then plummeted by 900.0% to -$40000.0 in 2021, then crashed by 535.0% to -$254000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$254000.0 in Q4 2022, $107000.0 in Q3 2022, and $154000.0 in Q2 2022.